Potent TLR4-dependent cell activation by Gram-negative bacterial endotoxin depends on sequential endotoxin-protein and protein-protein interactions with LBP, CD14, MD-2 and TLR4. LBP and CD14 combine, in an albumin-dependent fashion, to extract single endotoxin molecules from purified endotoxin aggregates (E agg ) or the bacterial outer membrane and form monomeric endotoxin:CD14 complexes that are the preferred presentation of endotoxin for transfer to MD-2. Endotoxin in endotoxin:CD14 is readily transferred to MD-2, again in an albumin-dependent manner, to form monomeric endotoxin:MD-2 complex. This monomeric endotoxin:protein complex (endotoxin:MD-2) activates TLR4 at picomolar concentrations, independently of albumin, and is, therefore, the apparent ligand in endotoxin-dependent TLR4 activation. Tetra-, penta-, and hexaacylated forms of meningococcal endotoxin (LOS) react similarly with LBP, CD14, and MD-2 to form endotoxin:MD-2 complexes. However, tetra-and penta-acylated LOS:MD-2 complexes are less potent TLR4 agonists than hexa-acylated LOS:MD-2. This is mirrored in the reduced activity of tetra-, penta-versus hexa-acylated LOS aggregates (LOS agg ) + LBP toward cells containing mCD14, MD-2, and TLR4. Therefore, changes in agonist potency of under-acylated meninigococcal LOS are determined by differences in properties of monomeric endotoxin:MD-2.
INTRODUCTION
It has long been established that the glycolipid, endotoxin (lipopolysaccharide, LPS), which comprises the outer leaflet of the outer membrane of Gram-negative bacteria, is responsible for provoking an array of potent pro-inflammatory responses in a rapid and highly sensitive manner. 1 Both sensitivity and speed are essential for initiating prompt host defense responses at the outset of Gram-negative bacterial invasion. Equally important is the ability of the host immune system to modulate the duration and intensity of host responses to endotoxin so as to avoid over-exuberant and sustained host inflammatory responses that, left unchecked, result in severe pathological consequences, including death. 2 One level of control is the extraordinary sensitivity of the host innate immune defense system to endotoxin. Understanding how the host defense system efficiently translates endotoxin recognition into pro-inflammatory responses and regulates endotoxin responsiveness is an area of intense study. Potent pro-inflammatory cellular responses to the presence of even a minute concentration of endotoxin or small number of Gram-negative bacteria is mediated through activation of Toll-like receptor 4 (TLR4) and its companion molecule, MD-2. 3, 4 Maximal response to endotoxin through TLR4-dependent activation is engineered by a specific sequential set of interactions with the extracellular and cell-surface bound endotoxin-binding proteins -lipopolysaccharide-binding protein (LBP), CD14 (soluble or membrane-bound) and MD-2 (either soluble or associated in the cell with TLR4). [3] [4] [5] Our approach to understanding the molecular mechanism of endotoxin-dependent TLR4 activation and the molecular basis of endotoxin potency has been to study the individual protein-endotoxin interactions necessary for TLR4-dependent cell activation by low concentrations of endotoxin. These interactions have been monitored in solution with purified endotoxin and endotoxin-binding proteins under conditions that facilitate relating the interactions observed in solution to cellular activation. In order to utilize such conditions, radioactively-labeled endotoxin isolated from an acetate auxotroph of Neisseria meningitidis serotype group B (NMBACE1) has been treated with LBP and sCD14 and a polyhistidine-tagged recombinant MD-2 that was generated from insect cells transfected with baculovirus containing human MD-2 DNA. [6] [7] [8] By requiring NMB to utilize radiolabeled acetate provided in the growth medium, the resultant purified endotoxin is of high specific radioactivity (6000-8000 cpm/ng for [ 3 H] or 600 cpm/ng for [ 14 C]) such that interactions at > 0.1 ng endotoxin can be monitored. Using purified proteins and radiolabeled LOS from NMB, gel filtration chromatography has allowed us to isolate endotoxin ± endotoxin-binding proteins in the form of complexes and/or aggregates. [6] [7] [8] The effect of subsequent interactions with a different endotoxin-binding protein on the physical nature/composition of an isolated complex and/or aggregate can be monitored in a similar manner. In addition, the isolated endotoxin complexes/aggregates can be used directly after gel sieving to evaluate their ability to produce TLR4-dependent cell activation.
Using the results of these studies, we have demonstrated that an isolated complex of monomeric LOS:MD-2 directly binds to and activates TLR4 at picomolar concentrations ( Fig. 1 ). 8 The LOS:MD-2 is both stable and watersoluble. More recently, we have applied these same solution techniques (size exclusion chromatography paired with bioactivity) to investigate where and how in this reaction sequence pathway, under-acylated endotoxin species demonstrate reduced potency. 
MATERIALS AND METHODS

Endotoxin preparation
[ 3 H]-or [ 14 C]-lipooligosaccharide (LOS) was isolated from the acetate auxotroph, NMBACE1, after metabolic labeling as previously described. 6 An msbB derivative of NMB, NMBA11K3cap -, was obtained from Dr Michael Apicella (Department of Microbiology, University of Iowa, Iowa City, IA, USA). Both strains were grown in minimal Morse medium supplemented with radioactive [ 3 H]-or [ 14 C]-acetate and the LOS isolated as described by Giardina et al. 6 Tetra-acylated LOS from NMBACE1 was prepared by deacylation with acyloxyacylhydrolase (AOAH) as described by Munford and Erwin. 10 LOS agg used as starting material to generate complexes was prepared by ultracentrifugation. 6 The [ 14 C]-fatty acid compositions of [ 14 C]-labeled endotoxins (purified aggregates and protein:endotoxin complexes) were confirmed by reversed-phase thin layer chromatography of chemically hydrolyzed samples as previously described. 6 Proteins LBP and sCD14 were provided by Xoma Corp. (Berkley, CA, USA). Recombinant soluble MD-2 containing a hexapolyhistidine tag on the carboxyl terminal end was prepared as described. 8 Acyloxyacylhydrolase (AOAH) was a generous gift from Dr Robert Munford (UT Southwestern Medical School, Dallas, TX, USA).
Gel filtration chromatography
Columns of Sephacryl S200 (1.5 cm x 30 cm or 70 cm) were equilibrated in Hanks' balanced salt solution, 10 mM HEPES, pH 7.4, ± 0.1% HSA. Aggregates and complexes were prepared as described using recombinant proteins and either [ 14 C]-or [ 3 H]-LOS agg by incubation at 37°C, 30 min before gel filtration chromatography. 6, 8 Fractions (1 ml) were collected (flow rate, 0.5 ml/min) at room temperature using GE Healthcare AKTA or AKTA Purifier ® FPLC. Aliquots of the collected fractions were analyzed by liquid scintillation spectroscopy using a Beckman LS liquid scintillation counter to detect radioactive LOS. Recoveries of LOS were > 70% ± albumin. All solutions used were pyrogen-free and sterile-filtered. After chromatography, selected fractions to be used in bioassays were pooled and passed through sterile syringe filters (0.22 µm) with greater than 90% recovery of radiolabeled material in the sterile filtrate. Fractions were stored under sterile conditions at 4°C for more than 1 month with no detectable changes in chromatographic or functional properties.
Cell activation assays
HEK293 cells transfected with sCD14, MD-2, and TLR4 were purchased from Invivogen (San Diego, CA, USA) and HEK293 ± TLR4 cells were a generous gift from Dr Jesse Chow (Eisai Institute, Andover, MA, USA). Human umbilical vein endothelial cells (HUVECs) were obtained from Clonetics. Cells have been extensively characterized and were cultured as has been described. 6, 8, 11 For cell activation assays, cells were grown to confluency in 48-well plates. Cell monolayers were washed with warm PBS 2x and incubated overnight at 37°C, 5% CO 2 , and 95% humidity in HBSS + , 0.1% HSA with the supplements as indicated. Activation of cells was assessed by measuring accumulation of extracellular IL-8 by ELISA as previously described. [6] [7] [8] 
RESULTS AND DISCUSSION
We have demonstrated that the use of an acetate auxotroph of NMB, NMBACE1, grown in the presence of either [ 3 H]-or [ 14 C]-acetate resulted in the production of radioactive LOS with a specific activity in the range of 6000-8000 cpm/ng and 600 cpm/ng, respectively. 6 Gel filtration chromatography on Sephacryl S500 showed that the major form of LOS was in the form of large aggregates (M r~2 0 x 10 6 Da; LOS agg ) consistent with thousands of LOS molecules per aggregate isolated.
Host responses to endotoxin are facilitated by LBP and CD14, the latter either in soluble or membrane form, and both proteins are essential for responses in cells like endothelial cells that contain endogenous MD-2/TLR4 (HUVECs), but only trace amounts of mCD14. 6, 7, 12 However, the amount of LBP relative to endotoxin is crucial in determining the fate of the endotoxin engaged by LBP. We have demonstrated that optimal conditions for TLR4-dependent activation of endothelial cells by LOS agg occur at substoichiometric concentrations of LBP with the optimal molar ratio of LOS:LBP ~200:1 and equimolar amounts of sCD14 to LOS. 6, 7, 13 Gel filtration chromatography in a balanced salt solution containing albumin was used to examine the individual effects of LBP and sCD14 on the physical presentation of LOS agg . Treatment of LOS agg with LBP (ratio 200:1) generates LOS agg :LBP that remains in a highly aggregated state (M r > 20 x 10 6 Da). Formation of a similar LBP containing aggregate is observed with [ 3 H]-LPS from Escherichia coli K12 LCD25. 14 In the absence of soluble CD14, the isolated LOS agg :LBP alone was inactive in triggering cellular responses from HUVECs. 6, 7, 13 Of note is the need for albumin to maintain the ability of LOS agg :LBP (or LPS agg :LBP) to activate cells via sCD14. 7 Subsequent treatment of the isolated LOS agg :LBP with sCD14 (at least equimolar CD14:LOS) in the presence of albumin resulted in disaggregation of LOS agg :LBP into complexes that can be isolated by gel sieving on Sephacryl S200 and that are monomers of LOS:sCD14 (M r~6 0 kDa). 6, 7 The isolated LOS:sCD14 complexes have the ability to activate HUVECs, cells that contain endogenous MD-2/TLR4, independently of the addition of LBP. 6 Engagement of a single aggregate of LOS by LBP facilitates the ability of CD14 to interact with and extract monomers of LOS from LOS agg :LBP and so produces thousands of molecules of LOS:sCD14 that now each have the capacity to activate endogenous MD-2/TLR4. Thus, the combined action of LBP and CD14 results in an amplification of the endotoxin signal by producing many active LOS:sCD14 monomers from one endotoxin aggregate. When LBP associates with LOS agg , a modification of LOS agg may occur that results in improved accessibility of individual LOS molecules to extraction by sCD14. This re-arrangement of the LOS aggregate may allow LOS to be more 'exposed' to the aqueous solvent and is consistent with a protective role of albumin in providing a hydrophobic pocket that protects the 'loosened' aggregate thus increasing its stability and acting as a shuttle for the transfer of a monomer to CD14. 7 CD14 engages the LBP-modified LOS agg such that formation of monomeric LOS:sCD14 is efficient (within 15 min at 37°C) and complete when equimolar or slightly greater amounts of sCD14 to LOS are provided. We have also observed a similar transformation with LPS from E. coli K12 LCD25. 8 This transfer to CD14, which confers a radical change in endotoxin presentation, requires albumin. 7 Albumin is also required for the stability of the monomeric LOS (LPS):sCD14 complexes. 7 In cells containing mCD14, a similar scenario could exist where the LOS agg :LBP engages mCD14 and transfer occurs to allow subsequent necessary molecular events with MD-2 and TLR4. Transfer of endotoxin from sCD14 to mCD14 is facile making it possible for endotoxin bound in the monomeric form to the soluble form of CD14 to be transferred in monomeric form to mCD14. 15 Formation of endotoxin:CD14 is followed by engagement of MD-2/TLR4 for activation. It has been shown by a number of laboratories that both surface cell expression and activation of TLR4 are dependent upon MD-2. 16, 17 Our laboratory has shown that an isolated endotoxin:MD-2 complex is, in fact, the ligand for TLR4; this has been deduced by others as well. 8, [18] [19] [20] We have reported that treatment of isolated LOS:sCD14 complexes with recombinant sMD-2 generates a monomeric complex of LOS:MD-2 that can be isolated by gel filtration chromatography using Sephacryl S200 (M r~2 0 kDa). 8 In contrast to MD-2 alone, this isolated LOS:MD-2 complex is stable even after incubation for as long as 6 h at 37°C (Levis, unpublished observations). Once formed, LOS:MD-2 has no requirement for albumin, and has the ability, in the absence of any other proteins, to activate TLR4 at exquisitely low concentrations. The half-maximal response of HEK293 cells transfected with TLR4 is ~30 pM; TLR4-dependent cell activation correlates with the ability of LOS:MD-2 to associate (bind) to TLR4-containing cells (for summary, see Table 1 ). 8 If the HEK293/TLR4 cells are pre-incubated with excess MD-2, washed, and then exposed to LOS:MD-2, no activation occurs suggesting that once engaged by MD-2, TLR4 is unable readily to exchange that MD-2 for the LOS:MD-2 complex (Teghanemt et al., unpublished observations). This finding also indicates that endotoxin is not readily transferred from one MD-2 molecule to another. This is in contrast to the rapid exchange of LOS from LOS:sCD14 to mCD14 or between sCD14 molecules (Kitchens and Munford; 15 Teghanemt, unpublished observations).
The transfer of LOS (from CD14) to MD-2 is essential for activation of TLR4, i.e. endotoxin:MD-2 is a necessary component of the TLR4-dependent activation pathway. 8, 17, 20 The reduced need for albumin once LOS:MD-2 is formed suggests that the interaction between the bound endotoxin and MD-2 is such that the hydrophobic portion of the lipid A is not as solvent exposed as in CD14, perhaps buried deeply and tightly bound to MD-2. If so, it would follow that direct transfer to TLR4 from MD-2 would be unlikely. We speculate that endotoxin-induced changes in MD-2 conformation result in further conformational/configurational changes between TLR4 and MD-2 that may lead to oligomerization of TLR4 (MD-2) and receptor activation. Studies on the structure-activity relationship in endotoxin have revealed that the fatty acids attached to lipid A play a major role in determining the potency of agonist properties of endotoxin (reviewed elsewhere 1,21-23 ). A major factor is the number, length, degree of saturation, and placement of the attached fatty acids. In a number of endotoxin species, variation in the extent of acylation of endotoxin has been shown to modify endotoxin potency as follows: hexa-acylated >> penta-or hepta-acylated ≥ tetra-acylated, with the tetra-acylated lipid IVA being an example of an endotoxin antagonist in human cells. 1, [21] [22] [23] Where within the sequence of molecular events with endotoxin-binding proteins that leads up to TLR4-dependent activation, the properties of under-acylated endotoxin species is apparent is not entirely defined. Using endotoxin deacylated by the enzyme acyloxyacylhydrolase (AOAH), Kitchens and Munford have shown that the product, tetra-acylated endotoxin, inhibited signaling and could compete with hexa-acylated endotoxin: (i) for reaction with LBP, if LBP was limiting; (ii) for reaction with CD14, if CD14 was limiting; and (iii) at some step post-CD14 interaction when neither LBP nor CD14 was limiting. 24 Based on recently acquired understanding of the role of MD-2 in TLR4-dependent activation, we predicted that endotoxin:MD-2 complexes formed with under-acylated endotoxins could be responsible for the reduced potency of these endotoxin variants. To test this hypothesis, we have utilized penta-acylated and tetra-acylated LOS and applied the gel sieving chromatography system coupled with bioassays of the isolated products to evaluate their ability to generate the individual complexes relative to wild-type NMB and the activity of the recovered complexes.
Endotoxin (LOS msbB ) with a penta-acylated lipid A was isolated from a strain of NMB (NMBA11K3cap -) described by Post et al. 9 
that carries an insertional inactivation
Monomeric endotoxin:protein complexes are essential for TLR4-dependent cell activation 121 of the acyltransferase gene msbB. An endotoxin containing a tetra-acylated lipid A structure was generated by treatment of wild-type NMBACE1 LOS with AOAH according to the procedure described by Munford and Erwin. 25 Applying the reaction scheme outlined for wildtype LOS, we have observed, as has been described by others, that isolated LOS from the msbB strain (LOS msbB ) and the AOAH-treated wild-type LOS (LOS AOAH ) were reduced in potency in activation of a transfected cell line containing CD14, MD-2, and TLR4 as measured by IL-8 production. 9, 26, 27 To determine if the reduced potency was a consequence of the inability to form a complex with MD-2, these LOS species were treated with LBP, sCD14, and recombinant sMD-2 and gel sieving was used to analyze the products formed from the reaction. Like wild-type LOS, both LOS msbB :MD-2 and LOS AOAH :MD-2 monomeric complexes were generated and could be isolated by gel sieving chromatography (Teghanemt et al., unpublished data). These complexes are similar to the wild-type LOS:MD-2 complex in their size and stability. However, LOS msbB :MD-2 and LOS AOAH :MD-2 have a reduced potency in activating TLR4 that exactly mirrors the reduced bioactivity observed with the starting LOS msbB or LOS AOAH aggregates (Teghanemt et al., unpublished observations). Since LOS msbB and LOS AOAH are able to form stable complexes with MD-2, the reactivity of LBP, sCD14, and MD-2 with endotoxin is not markedly changed by differences in the numbers of fatty acids attached to lipid A. Discrimination in bioactivity must, therefore, occur at the level of interaction with TLR4. The LOS:MD-2 complexes formed may have impaired ability to interact with TLR4 effectively. For example, the MD-2 complex may associate with TLR4, but the interaction may not be optimal in initiating conformational changes that are necessary to trigger oligomerization of TLR4 and subsequent receptor activation (Fig. 2) . Alternatively, the complex may form, but be unable to associate with TLR4 effectively. While the mechanism by which the LOS:MD-2 complex activates TLR4 is still uncertain, these findings demonstrate for the first time that a monomeric endotoxin:protein complex, not the aggregate properties of endotoxin, determines endotoxin potency.
In summary, it is the sequential interactions of endotoxin with LBP, sCD14, and MD-2 that together permit potent TLR4 activation by minute amounts of endotoxin. These reactions produce stepwise changes in the presentation of endotoxin molecules that facilitate extraction and transfer of endotoxin monomers first to CD14 and then to MD-2. These co-ordinated reactions transform an aggregate of purified endotoxin (or membrane-associated endotoxin) to a monomeric endotoxin:MD-2 complex that triggers TLR4-dependent activation. The role of albumin in this reaction scheme is to provide during this series of transitions, an environment that protects the partially exposed hydrophobic lipid A from unfavorable exposure to the aqueous surrounding environment. The exposure of lipid A in the quasi-stable monomeric endotoxin:CD14 complex is also consistent with increased sensitivity of this complex to the deacylating enzyme AOAH (Fig. 2; Gioannini et al. , Poster 125, International Endotoxin Society Conference, Kyoto, Japan, 2004). This would provide a mechanism by which the potency of this pro-inflammatory pathway may be dampened. It is the properties of the monomeric endotoxin:MD-2 complex, as defined at least in part by the acylation state of the endotoxin, that determines both efficacy of TLR4 association and subsequent cell activation.
